Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeliosX operates the world’s largest vertically integrated healthcare network of clinicians and pharmacies for asynchronous telemedicine consultations and prescription fulfillment across the UK, US, and Europe. It has helped over two million customers in 2024 with an average NPS score of 70. The group covers more than thirty core medical conditions through its brands Dermatica (personalized dermatology), MedExpress (telepharmacy), Levity (weight loss), ZipHealth (US-based online medical consultations/pharmacy), RocketRx (men’s health), PharmacyLab. Revenue grew from £60m to £180m between 2023–2024 without external funding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeliosX.